VE-800

N/A

Report date: 2024/01/23 15:26:40

Base Information

Drug NameVE-800
Drug Alias NameVE-800
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionCluster of differentiation 8 stimulants
TargetsCluster of differentiation 8
Therapy Area/IndicationsGastroesophageal Junction NeoplasmsNeoplasm MetastasisStomach Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVedanta Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesVedanta Biosciences Inc
Inactive CompaniesN/A
Active IndicationsGastroesophageal Junction NeoplasmsNeoplasm MetastasisStomach Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A